Integer Holdings Corp (ITGR) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.038x

Based on the latest financial reports, Integer Holdings Corp (ITGR) has a cash flow conversion efficiency ratio of 0.038x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($65.59 Million) by net assets ($1.75 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Integer Holdings Corp - Cash Flow Conversion Efficiency Trend (1999–2024)

This chart illustrates how Integer Holdings Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Integer Holdings Corp (ITGR) total liabilities for a breakdown of total debt and financial obligations.

Integer Holdings Corp Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Integer Holdings Corp ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Twist Bioscience Corp
NASDAQ:TWST
-0.054x
Mivne Real Estate KD Ltd
TA:MVNE
0.029x
Tikehau Capital
PA:TKO
0.074x
Virbac SA
PA:VIRP
0.023x
Northeast Securities Co Ltd
SHE:000686
-0.401x
Wanda Cinema Line Corp
SHE:002739
0.061x
Sunrun Inc
NASDAQ:RUN
0.019x
OPENLANE, Inc.
NYSE:OPLN
0.035x

Annual Cash Flow Conversion Efficiency for Integer Holdings Corp (1999–2024)

The table below shows the annual cash flow conversion efficiency of Integer Holdings Corp from 1999 to 2024. For the full company profile with market capitalisation and key ratios, see Integer Holdings Corp (ITGR) market capitalisation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 $1.62 Billion $205.21 Million 0.127x +6.82%
2023-12-31 $1.52 Billion $180.21 Million 0.119x +44.49%
2022-12-31 $1.42 Billion $116.38 Million 0.082x -29.00%
2021-12-31 $1.35 Billion $156.67 Million 0.116x -18.94%
2020-12-31 $1.27 Billion $181.34 Million 0.143x -0.56%
2019-12-31 $1.15 Billion $165.36 Million 0.143x -9.05%
2018-12-31 $1.06 Billion $167.30 Million 0.158x -5.64%
2017-12-31 $893.38 Million $149.36 Million 0.167x +14.89%
2016-12-31 $725.24 Million $105.53 Million 0.146x +891.89%
2015-12-31 $850.62 Million $12.48 Million 0.015x -88.91%
2014-12-31 $614.25 Million $81.28 Million 0.132x +26.37%
2013-12-31 $542.05 Million $56.76 Million 0.105x -22.34%
2012-12-31 $480.86 Million $64.83 Million 0.135x -29.94%
2011-12-31 $467.28 Million $89.92 Million 0.192x +6.83%
2010-12-31 $426.83 Million $76.89 Million 0.180x -4.69%
2009-12-31 $379.72 Million $71.77 Million 0.189x +24.35%
2008-12-31 $375.69 Million $57.10 Million 0.152x +14.15%
2007-12-31 $322.67 Million $42.97 Million 0.133x +1.79%
2006-12-31 $299.69 Million $39.20 Million 0.131x -18.92%
2005-12-31 $268.61 Million $43.34 Million 0.161x -7.87%
2004-12-31 $257.91 Million $45.17 Million 0.175x -24.79%
2003-12-31 $235.34 Million $54.80 Million 0.233x +73.21%
2002-12-31 $206.86 Million $27.81 Million 0.134x +18.33%
2001-12-31 $188.84 Million $21.45 Million 0.114x -15.02%
2000-12-31 $135.83 Million $18.16 Million 0.134x -31.00%
1999-12-31 $46.41 Million $8.99 Million 0.194x --

About Integer Holdings Corp

NYSE:ITGR USA Medical Devices
Market Cap
$3.02 Billion
Market Cap Rank
#4977 Global
#1574 in USA
Share Price
$86.29
Change (1 day)
+0.51%
52-Week Range
$63.32 - $122.97
All Time High
$144.36
About

Integer Holdings Corporation operates as a medical device contract development and manufacturing company in the United States, Puerto Rico, Costa Rica, and internationally. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-v… Read more